Peer-reviewedLicence not statedFuture Oncology
MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis
4 affiliations
- 1Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- 2Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- 3Department of Medical Oncology, Chengdu Shangjinnanfu Hospital, West China Hospital of Sichuan University, Chengdu, Sichuan, China
- 4School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Related
- Preparation of chitosan oligosaccharide-porphyrin conjugate and its photodynamic preservation effect on Litopenaeus vannamei.
- Histologically Confirmed Brain Metastasis Arising From Giant Cell Tumor of Bone: an Uncommon Entity and a Challenging Condition.
- Organ Preservation and Quality of Life After Total Neoadjuvant Treatment in Rectal Cancer
- Patient-reported Symptom Resolution After Neoadjuvant Versus Adjuvant Chemotherapy for Early Breast Cancer: A Prospective Observational Cohort Study
- Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer
BibTeX
@article{wang2026mhpenile002,
title = {{MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis}},
author = {Jia-Yao Wang and Yan-Xiang Shao and Li-Li Yang and Hong-Shuai Li and Jia-Qi Liu and Rui-Zhi Liu and Shuang Zhang and Xiang Li and Ji-Yan Liu},
journal = {Future Oncology},
year = {2026},
month = sep,
doi = {10.1080/14796694.2026.2732579},
url = {https://doi.org/10.1080/14796694.2026.2732579},
}
RIS
TY - JOUR
TI - MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis
AU - Jia-Yao Wang
AU - Yan-Xiang Shao
AU - Li-Li Yang
AU - Hong-Shuai Li
AU - Jia-Qi Liu
AU - Rui-Zhi Liu
AU - Shuang Zhang
AU - Xiang Li
AU - Ji-Yan Liu
PY - 2026
DA - 2026/09/18
JO - Future Oncology
DO - 10.1080/14796694.2026.2732579
UR - https://doi.org/10.1080/14796694.2026.2732579
SN - 1479-6694
SN - 1744-8301
ER -